Skip to main content
Ramin Sedaghat Herati on Muck Rack

Ramin Sedaghat Herati

As seen in: Nature, Annals of the Rheumatic Diseases, EBioMedicine, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ramin Sedaghat

Contact Ramin Sedaghat, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A comparison of two- and three-dose MVA-BN mpox vaccination series on anti-monkeypox virus immunity

|
By Aaron L. Oom, Kesi K Wilson, Marie I. Samanovic, Angelica C. Kottkamp, Ramin Sedaghat Herati, Ralf Duerr, Mark Mulligan Verified, Stephanie Rettig, Michael Tuen
| Nature Verified
Abstract The 2022 global outbreak of clade IIb mpox represented a turning point in public health’s handling of poxviruses. The primary vaccine available for the prevention of mpox is modified vaccinia Ankara from Bavarian-Nordic (MVA-BN). We previously reported a nondurable and low-avidity antibody response against mpox elicited by MVA-BN.
Open in Who Shared Issue with article?

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine - Nature Immunology

|
By Ramin Sedaghat Herati, David A. Knorr, Laura A Vella, Sokratis A Apostolidis, Alexander Huang, Alexander D Muselman, Stylianos Bournazos, Samuel A. Funt, Martin H. Voss, Robert J. Motzer, Chung-Han Lee, Dean F. Bajorin, Tara Mitchell, E. John Wherry
| Nature Verified
Abstract Anti-programmed death-1 (anti-PD-1) immunotherapy reinvigorates CD8 T cell responses in patients with cancer but PD-1 is also expressed by other immune cells, including follicular helper CD4 T cells (Tfh) which are involved in germinal centre responses. Little is known, however, about the effects of anti-PD-1 immunotherapy on noncancer immune responses in humans.
Open in Who Shared Issue with article?

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

|
By Rebecca Haberman, Ramin Sedaghat Herati, David Simon, Marie I. Samanovic
| Annals of the Rheumatic Diseases Verified
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease Rebecca H Haberman1,2, Ramin Herati3,4, http://orcid.org/0000-0001-8310-7820David Simon5,6, Marie Samanovic3,4, Rebecca B Blank1,4, Michael Tuen3,4, Sergei B Koralov7, Raja Atreya6,8, Koray Tascilar5,6, Joseph R Allen3, Rochelle Castillo1,2, Amber R Cornelius3, Paula Rackoff1, Gary Solomon1, Samrachana Adhikari9, Natalie Azar1, Pamela Rosenthal1, Peter Izmirly1, Jonathan Samuels1,10,...
Open in Who Shared Issue with article?
See all 10 articles